Philippe Gevaert

29.2k total citations · 11 hit papers
186 papers, 12.4k citations indexed

About

Philippe Gevaert is a scholar working on Immunology and Allergy, Physiology and Otorhinolaryngology. According to data from OpenAlex, Philippe Gevaert has authored 186 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Immunology and Allergy, 112 papers in Physiology and 106 papers in Otorhinolaryngology. Recurrent topics in Philippe Gevaert's work include Asthma and respiratory diseases (111 papers), Allergic Rhinitis and Sensitization (110 papers) and Sinusitis and nasal conditions (106 papers). Philippe Gevaert is often cited by papers focused on Asthma and respiratory diseases (111 papers), Allergic Rhinitis and Sensitization (110 papers) and Sinusitis and nasal conditions (106 papers). Philippe Gevaert collaborates with scholars based in Belgium, United States and United Kingdom. Philippe Gevaert's co-authors include Claus Bachert, Paul Van Cauwenberge, Gabriële Holtappels, Thibaut Van Zele, Peter W. Hellings, Natalie De Ruyck, Joaquim Mullol, Claudina Pérez-Novo, S. G. O. Johansson and Sofie Claeys and has published in prestigious journals such as The Lancet, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Philippe Gevaert

173 papers receiving 12.1k citations

Hit Papers

Differentiation of chronic sinus diseases by measurement ... 2001 2026 2009 2017 2006 2016 2012 2001 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Differentiation of chronic sinus diseases by measurement of inflammatory mediators
    2006 635 citations Thibaut Van Zele, Philippe Gevaert et al. Allergy profile →
  2. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis
    2016 553 citations Claus Bachert, Leda Mannent et al. profile →
  3. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
    2012 527 citations Philippe Gevaert, Lien Calus et al. Journal of Allergy and Clinical Immunology profile →
  4. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
    2001 518 citations Claus Bachert, Philippe Gevaert et al. Journal of Allergy and Clinical Immunology profile →
  5. Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
    2011 457 citations Philippe Gevaert, Thibaut Van Zele et al. Journal of Allergy and Clinical Immunology profile →
  6. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
    2020 453 citations Philippe Gevaert, Theodore A. Omachi et al. Journal of Allergy and Clinical Immunology profile →
  7. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
    2017 352 citations Claus Bachert, Ana R. Sousa et al. Journal of Allergy and Clinical Immunology profile →
  8. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management
    2020 213 citations Claus Bachert, Stella E. Lee et al. Journal of Allergy and Clinical Immunology profile →
  9. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial
    2021 205 citations Claus Bachert, Joseph K. Han et al. Journal of Allergy and Clinical Immunology profile →
  10. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023
    2023 152 citations Diego M. Conti, Philippe Gevaert et al. Rhinology Journal profile →
  11. Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
    2025 17 citations Philippe Gevaert, Marjolein Cornet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Gevaert Belgium 62 7.7k 7.7k 7.5k 3.1k 1.7k 186 12.4k
Gabriële Holtappels Belgium 44 4.8k 0.6× 5.7k 0.7× 5.0k 0.7× 2.0k 0.7× 1.1k 0.6× 122 8.3k
Anju T. Peters United States 47 4.0k 0.5× 5.2k 0.7× 3.5k 0.5× 2.3k 0.8× 1.1k 0.6× 218 7.6k
Whitney W. Stevens United States 33 2.0k 0.3× 2.3k 0.3× 1.8k 0.2× 982 0.3× 593 0.3× 99 3.9k
Gianluca Pirozzi United States 31 4.2k 0.5× 761 0.1× 4.3k 0.6× 855 0.3× 1.2k 0.7× 85 7.7k
Martin Desrosiers Canada 31 1.4k 0.2× 2.1k 0.3× 1.4k 0.2× 1.0k 0.3× 506 0.3× 119 3.8k
Kathleen E. Harris United States 30 1.4k 0.2× 1.2k 0.2× 1.4k 0.2× 495 0.2× 527 0.3× 105 3.3k
Jennifer D. Hamilton United States 24 2.3k 0.3× 499 0.1× 2.4k 0.3× 715 0.2× 717 0.4× 81 5.0k
Lennart Greiff Sweden 33 1.7k 0.2× 517 0.1× 2.3k 0.3× 595 0.2× 1.3k 0.8× 180 4.2k
Alex KleinJan Netherlands 36 1.8k 0.2× 256 0.0× 2.8k 0.4× 862 0.3× 1.3k 0.8× 80 4.8k

Countries citing papers authored by Philippe Gevaert

Since Specialization
Citations

This map shows the geographic impact of Philippe Gevaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Gevaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Gevaert more than expected).

Fields of papers citing papers by Philippe Gevaert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Gevaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Gevaert. The network helps show where Philippe Gevaert may publish in the future.

Co-authorship network of co-authors of Philippe Gevaert

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Gevaert. A scholar is included among the top collaborators of Philippe Gevaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Gevaert. Philippe Gevaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hellings, Peter W., Eugenio De Corso, Vibeke Backer, et al.. (2025). Remission in chronic rhinosinusitis with nasal polyps. Rhinology Journal. 0(0). 0–0. 1 indexed citations
2.
Lee, Stella E., Amber Luong, Anju T. Peters, et al.. (2025). A Study of Dupilumab in Adults with CRSsNP: Results from the Liberty ORION study. Journal of Allergy and Clinical Immunology. 155(2). AB76–AB76. 1 indexed citations
3.
Alsaleh, Saad, Claire Hopkins, Osama Marglani, et al.. (2024). Assessment of chronic rhinosinusitis with nasal polyps: Development of the Nasal Polyp Patient Assessment Scoring Sheet tool. Laryngoscope Investigative Otolaryngology. 9(3). e1277–e1277.
4.
Conti, Diego M., Vibeke Backer, Leif Bjermer, et al.. (2024). EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus. Pediatric Allergy and Immunology. 35(7).
5.
Bachert, Claus, Asif Khan, Wytske J. Fokkens, et al.. (2024). Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP. Journal of Allergy and Clinical Immunology. 154(6). 1442–1449. 3 indexed citations
6.
Desrosiers, Martin, Zuzana Diamant, Paolo Castelnuovo, et al.. (2023). Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up. International Forum of Allergy & Rhinology. 14(1). 18–31. 19 indexed citations
7.
Gevaert, Philippe, Joseph K. Han, Steven G. Smith, et al.. (2022). The roles of eosinophils and interleukin‐5 in the pathophysiology of chronic rhinosinusitis with nasal polyps. International Forum of Allergy & Rhinology. 12(11). 1413–1423. 73 indexed citations
8.
Corren, Jonathan, Claus Bachert, Philippe Gevaert, et al.. (2020). Omalizumab Improves Quality of Life in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma. Journal of Allergy and Clinical Immunology. 145(2). AB250–AB250. 3 indexed citations
9.
Vlaminck, Stephan, Frederic Acke, Emmanuel Prokopakis, et al.. (2020). Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 Years. American Journal of Rhinology and Allergy. 35(4). 449–457. 40 indexed citations
10.
Gevaert, Philippe, Peter W. Hellings, J. Mullol, et al.. (2020). Omalizumab is associated with a reduced need for surgery in patients with nasal polyposis. Allergy. 75. 108–108. 1 indexed citations
11.
Lyly, Annina, Anu Laulajainen‐Hongisto, Philippe Gevaert, Paula Kauppi, & Sanna Toppila‐Salmi. (2020). Monoclonal Antibodies and Airway Diseases. International Journal of Molecular Sciences. 21(24). 9477–9477. 10 indexed citations
12.
Bachert, Claus, Peter W. Hellings, Joaquim Mullol, et al.. (2019). Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 75(1). 148–157. 74 indexed citations
13.
Gevaert, Philippe, Natalie De Ruyck, Lara Derycke, et al.. (2018). FcεRI expression and IgE binding by dendritic cells and basophils in allergic rhinitis and upon allergen immunotherapy. Clinical & Experimental Allergy. 48(8). 970–980. 30 indexed citations
14.
Vermeulen, Hester, Natalie De Ruyck, Lara Derycke, et al.. (2017). Probiotics-impregnated bedding covers in house dust mite allergic rhinitis patients : a double-blind, randomised, placebo-controlled, crossover clinical trial. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
15.
Derycke, Lara, Lien Calus, Gabriële Holtappels, et al.. (2017). The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps. Rhinology Journal. 55(2). 152–160. 27 indexed citations
16.
Zele, Thibaut Van, et al.. (2015). Comparison of different medical treatment options for CRSwNP : doxycycline, methylprednisolone, mepolizumab and omalizumab. Allergy. 70. 442–442. 1 indexed citations
17.
Calus, Lien, et al.. (2014). Use of paper filter discs for measurement of local biomarkers of nasal mucosal inflammation. Ghent University Academic Bibliography (Ghent University).
18.
Kormelink, Tom Groot, Lien Calus, Natalie De Ruyck, et al.. (2012). Local free light chain expression is increased in chronic rhinosinusitis with nasal polyps. Allergy. 67(9). 1165–1172. 17 indexed citations
19.
Huvenne, Wouter, et al.. (2007). Upper airway inflammation in chronic smoke exposed mice. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriële Holtappels Breakdown of academic impact, for papers by Anju T. Peters Breakdown of academic impact, for papers by Whitney W. Stevens Breakdown of academic impact, for papers by Gianluca Pirozzi Breakdown of academic impact, for papers by Martin Desrosiers Breakdown of academic impact, for papers by Kathleen E. Harris Breakdown of academic impact, for papers by Jennifer D. Hamilton Breakdown of academic impact, for papers by Lennart Greiff Breakdown of academic impact, for papers by Alex KleinJan
Rankless by CCL
2026